HK1174562A1 - Aerosol formulation for copd copd - Google Patents

Aerosol formulation for copd copd

Info

Publication number
HK1174562A1
HK1174562A1 HK13101925.3A HK13101925A HK1174562A1 HK 1174562 A1 HK1174562 A1 HK 1174562A1 HK 13101925 A HK13101925 A HK 13101925A HK 1174562 A1 HK1174562 A1 HK 1174562A1
Authority
HK
Hong Kong
Prior art keywords
copd
aerosol formulation
aerosol
formulation
copd copd
Prior art date
Application number
HK13101925.3A
Other languages
English (en)
Chinese (zh)
Inventor
．邦奈利
．尤斯伯特
．扎姆貝裡
Original Assignee
奇斯藥製品公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 奇斯藥製品公司 filed Critical 奇斯藥製品公司
Publication of HK1174562A1 publication Critical patent/HK1174562A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B3/00—Packaging plastic material, semiliquids, liquids or mixed solids and liquids, in individual containers or receptacles, e.g. bags, sacks, boxes, cartons, cans, or jars
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B7/00—Closing containers or receptacles after filling
    • B65B7/16—Closing semi-rigid or rigid containers or receptacles not deformed by, or not taking-up shape of, contents, e.g. boxes or cartons

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mechanical Engineering (AREA)
  • Otolaryngology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
HK13101925.3A 2009-12-23 2013-02-15 Aerosol formulation for copd copd HK1174562A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09180662 2009-12-23
PCT/EP2010/070476 WO2011076840A2 (en) 2009-12-23 2010-12-22 Aerosol formulation for copd

Publications (1)

Publication Number Publication Date
HK1174562A1 true HK1174562A1 (en) 2013-06-14

Family

ID=42102003

Family Applications (1)

Application Number Title Priority Date Filing Date
HK13101925.3A HK1174562A1 (en) 2009-12-23 2013-02-15 Aerosol formulation for copd copd

Country Status (10)

Country Link
US (3) US20110146677A1 (ru)
EP (1) EP2515856B1 (ru)
KR (2) KR20120106753A (ru)
CN (1) CN102695496B (ru)
BR (1) BR112012015335B1 (ru)
CA (1) CA2785347C (ru)
ES (1) ES2467928T3 (ru)
HK (1) HK1174562A1 (ru)
RU (1) RU2567040C2 (ru)
WO (1) WO2011076840A2 (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2515853B1 (en) * 2009-12-23 2014-03-19 Chiesi Farmaceutici S.p.A. Combination therapy for COPD
PE20121467A1 (es) 2009-12-23 2012-11-07 Chiesi Farma Spa Formulacion de aerosol para la enfermedad pulmonar obstructiva cronica
UA113832C2 (xx) * 2009-12-23 2017-03-27 Комбінаційна терапія для хозл
CN111150728B (zh) 2013-12-30 2024-02-06 奇斯药制品公司 格隆溴铵和福莫特罗组合的稳定的加压气雾剂溶液组合物
NO3096737T3 (ru) 2013-12-30 2018-09-01
EA202000218A1 (ru) * 2018-01-23 2021-03-03 Александр Григорьевич ЧУЧАЛИН Фармацевтическая композиция (варианты), применение фармацевтической композиции (варианты)

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6204285B1 (en) * 1996-07-01 2001-03-20 Sepracor Inc. Methods and compositions for treating urinary incontinence using enantiomerically enriched (R,R)-glycopyrrolate
US20010021950A1 (en) * 1998-07-10 2001-09-13 Michael Hawley Method and apparatus for controlling access to a computer network using tangible media
EP1131059B1 (de) * 1998-11-13 2003-03-05 Jago Research Ag Trockenpulver zur inhalation
IT1317720B1 (it) 2000-01-07 2003-07-15 Chiesi Farma Spa Dispositivo per la somministrazione di aerosol dosati pressurizzati inpropellenti idrofluoroalcani.
GB0008660D0 (en) 2000-04-07 2000-05-31 Arakis Ltd The treatment of respiratory diseases
US20060257324A1 (en) * 2000-05-22 2006-11-16 Chiesi Farmaceutici S.P.A. Pharmaceutical solution formulations for pressurised metered dose inhalers
AU2002234476B2 (en) * 2001-03-30 2006-04-27 Jagotec Ag Medical aerosol formulations
EP1321159A1 (en) 2001-12-21 2003-06-25 CHIESI FARMACEUTICI S.p.A. Pressurized metered dose inhaler (pMDI) actuators with laser drilled orifices
CA2550841C (en) * 2004-02-06 2012-10-02 Meda Pharma Gmbh & Co. Kg Novel combination of anticholinergic and .beta. mimetics for the treatment of respiratory diseases
GB0410399D0 (en) 2004-05-10 2004-06-16 Arakis Ltd The treatment of respiratory disease
US7915303B2 (en) 2005-03-24 2011-03-29 Sosei R&D Ltd. Glycopyrronium salts and their therapeutic use
GB0613161D0 (en) * 2006-06-30 2006-08-09 Novartis Ag Organic Compounds
ES2969237T3 (es) * 2007-10-18 2024-05-17 Rose U Llc Formulaciones tópicas de glicopirrolato y una toallita que contiene las mismas

Also Published As

Publication number Publication date
BR112012015335A2 (pt) 2016-03-15
RU2012125965A (ru) 2013-12-27
EP2515856A2 (en) 2012-10-31
US20180021301A1 (en) 2018-01-25
RU2567040C2 (ru) 2015-10-27
KR20120106753A (ko) 2012-09-26
CA2785347C (en) 2018-02-27
BR112012015335B1 (pt) 2021-05-18
US20110146677A1 (en) 2011-06-23
ES2467928T3 (es) 2014-06-13
KR101795348B1 (ko) 2017-12-01
KR20170060618A (ko) 2017-06-01
CN102695496B (zh) 2014-10-01
EP2515856B1 (en) 2014-04-02
WO2011076840A3 (en) 2011-12-01
US20140363383A1 (en) 2014-12-11
CA2785347A1 (en) 2011-06-30
WO2011076840A2 (en) 2011-06-30
CN102695496A (zh) 2012-09-26

Similar Documents

Publication Publication Date Title
HK1174568A1 (en) Aerosol formulation for copd copd
EP2581431A4 (en) AEROSOL COMPOSITION
GB2479609B (en) Aerosol spray device
IL218931A0 (en) Aerosol genetrator including multi-component wick
EP2579851A4 (en) SOFTMAKER AEROSOL FOAM COMPOSITIONS OF HIGH OIL CONTENT
EP2608830A4 (en) AEROSOL DISPENSER
GB201212846D0 (en) Improved neck-finish for an aerosol container
GB2475393B (en) Aerosol spray device
EP2614815A4 (en) FOAMABLE AEROSOL COMPOSITION
AU336863S (en) Aerosol dispenser
IL213990A0 (en) Compositions for decontamination
EP2602209A4 (en) OPERATOR FOR AN AEROSOL VESSEL
GB0907003D0 (en) Formulation
ZA201208127B (en) Aerosol compositions
PT2298452T (pt) Dispositivo de aerossol
HK1174562A1 (en) Aerosol formulation for copd copd
ZA201103347B (en) Pharmaceutical aerosol composition
EP2413905A4 (en) COMPOSITION
PL2338587T3 (pl) Urządzenie do wytwarzania aerozolu
PL2566780T3 (pl) Urządzenie uruchamiające dla pojemnika aerozolowego
GB0913699D0 (en) Scientific aerosol
GB0918149D0 (en) Improved medicinal aerosol formulation
PT2308690E (pt) Recipiente para pintura
GB201005000D0 (en) Dispenser for powder
GB0911213D0 (en) Formulation